HCWB 1 (-1.96%)
US40423R1059BiotechnologyBiotechnology

HCW Biologics (HCWB) Stock Highlights

1 | -1.96%
2024-06-21 06:26:26
HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

Statistics

Range Today
0.93 1.03
Volume Today 6.3K
Range 1 Year
0.91 2.32
Volume 1 Year 3.47M
Range 3 Year
0.91 7.78
Volume 3 Year 215.64M
Range 10 Year
0.91 7.78
Volume 10 Year 215.64M

Highlights

Market Capitalization 42.36M (micro)
Floating Shares 17.85M
Current Price 1
Price To Earnings -1.37
Price To Revenue 11.86
Price To Book 4.85
Earnings Per Share -0.76
Payout Ratio 0%

Performance

Latest -1.96%
1 Month -9.09%
3 Months -41.18%
6 Months -21.26%
1 Year -52.61%
3 Years -86.67%
5 Years -86.67%
10 Years -86.67%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.